ASCO Living Guideline | Therapy for stage IV non–small-cell lung cancer without driver alterations.
12 Jul, 2022 | 12:44h | UTC
Commentary on Twitter
Now available in #JCO: Key updated first-line recommendations on therapy for stage IV #NSCLC ? without driver alterations by @ns_chd et al. ➡️ https://t.co/KovrwEtYGz #lungcancer #lcsm pic.twitter.com/iQONRkgxsj
— Journal of Clinical Oncology (@JCO_ASCO) July 11, 2022